MedPath

FAGOTTO study

Not Applicable
Recruiting
Conditions
Diabetes Mellitus, Type 2
D003924
Registration Number
JPRN-jRCTs041200069
Lead Sponsor
Maruyama Shoichi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
110
Inclusion Criteria

patients with stable type 2 diabetes
-eGFR(Crteatinine)<= 60mL/min/1.73m2
-patients who are taking renin angiotensin system inhibitors (exclude intolerable or non-adaptive)
-older than 18 years
-written consent

Exclusion Criteria

-SGLT2 inhibitors users within 8 weeks
-30-under maintenance dialysis therapy or history of kidney plantation
-diuretics users
-patients who are taking both ACEi and ARB (renin inhibitor)
-active nephritis or kidney disease
-obvious steroid diabetes
-patients whose ALT and AST levels exceed 2.0 times the facility standard value
-heart failure NYHA class 4
-pregnant, or desiring to bear children
-inapporopriate for this study as judged by attending investigateor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath